Woburn, MA · Founded 2018 · Privately Held (backing)
Developer of a data-driven mRNA target identification platform intended to develop RNA-targeting medicines. Rgenta Therapeutics is based in Woburn, MA and was founded in 2018. It was valued at $119 million at its later-stage round in Nov 2022, the last priced event on record. It has raised $98.9 million across 2 recorded rounds; the latest was an $8.9 million early-stage round in Nov 2021.
PMV mark · valuation
$119.0M
Oct 2026
Priced at
its later-stage round
Nov 2022
Total raised
$98.9M
Last round
Early Stage VC
Nov 2021
Team — not yet on record
No current team members for Rgenta Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Rgenta Therapeutics with a free account
·The complete investor list: 13 names
·Watch Rgenta Therapeutics: the Monday email on marks, rounds and moves
